Screening of Alzheimer’s disease with multiwavelength Stokes polarimetry in a mouse model

Mariia Borovkova; Oleksii Sieryi; Ivan Lopushenko; Natalia Kartashkina; Jens Pahnke; Alexander Bykov; Igor Meglinski

doi:10.1109/TMI.2021.3129700

Screening of Alzheimer’s disease with multiwavelength Stokes polarimetry in a mouse model

Mariia Borovkova^*, Oleksii Sieryi, Ivan Lopushenko, Natalia Kartashkina, Jens Pahnke, Alexander Bykov, Igor Meglinski^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

The minimum histological criterion for the diagnostics of Alzheimer’s disease (AD) in tissue is the presence of senile plaques and neurofibrillary tangles in specific brain locations. The routine procedure of morphological analysis implies time-consuming and laborious steps including sectioning and staining of formalin-fixed paraffin-embedded (FFPE) tissue. We developed a multispectral Stokes polarimetric imaging approach that allows characterization of FFPE brain tissue samples to discern the stages of AD progression without sectioning and staining the tissue. The Stokes polarimetry approach is highly sensitive to structural alterations of brain tissue, particularly to the changes in light scattering and birefringence. We present the results of the label-free non-destructive screening of FFPE mouse brain tissue and show several polarization metrics that demonstrate statistically significant differences for tissues at different stages of AD.

Original language	English
Number of pages	7
Journal	IEEE Transactions on Medical Imaging
Early online date	22 Nov 2021
DOIs	https://doi.org/10.1109/TMI.2021.3129700
Publication status	E-pub ahead of print - 22 Nov 2021

Bibliographical note

This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/

Funding: This work was supported by the Academy of Finland (grants 314369 and 325097), the ATTRACT project funded by the EC under Grant Agreement
777222, the INFOTECH strategic fund. The work of Mariia Borovkova was also supported by the European Union’s Horizon 2020 research and
innovation programme under the Marie Skłodowska-Curie grant agreement No.713606. The work of Jens Pahnke was supported by the following
grants: Deutsche Forschungsgemeinschaft/ Germany (DFG 263024513); Latvian Council of Science/ Latvia (ShortAbeta lzp-2018/1-0275);
HelseSØ/ Norway (2019054, 2019055); EEA grant/Norges grants (TAČR TARIMAD TO100078); Norges forskningsrådet/ Norway (260786 PROPAD, 295910 NAPI, PETABC); European Commission (643417). PROP-AD and PETABC are EU Joint Programme - Neurodegenerative Disease
Research (JPND) projects. PROP-AD is supported through the following funding organizations under the aegis of JPND - www.jpnd.eu. The research
was also partially supported by a grant under the Decree of the Government of the Russian Federation No. 220 of 09 April 2010 (Agreement No.
075-15-2021-615 of 04 June 2021) and the Ministry of Science and Higher Education of the Russian Federation within the framework of state support
for the creation and development of World-Class Research Centers “Digital biodesign and personalized healthcare” № 075-15-2020-926

Keywords

Ab plaques
Brain
Laser beams
Measurement by laser beam
Mice
Microscopy
Optical microscopy
Optical polarimetry
Polarimetry
Stokes vector
birefringence
scattering

Access to Document

10.1109/TMI.2021.3129700Licence: CC BY 3.0

Screening_of_Alzheimers_disease_with_multiwavelength_Stokes_polarimetry_in_a_mouse_model
This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/
Accepted author manuscript, 858 KBLicence: CC BY 3.0

Cite this

@article{48c9184490cc491ea4e6cb98598fbbaa,

title = "Screening of Alzheimer{\textquoteright}s disease with multiwavelength Stokes polarimetry in a mouse model",

abstract = "The minimum histological criterion for the diagnostics of Alzheimer{\textquoteright}s disease (AD) in tissue is the presence of senile plaques and neurofibrillary tangles in specific brain locations. The routine procedure of morphological analysis implies time-consuming and laborious steps including sectioning and staining of formalin-fixed paraffin-embedded (FFPE) tissue. We developed a multispectral Stokes polarimetric imaging approach that allows characterization of FFPE brain tissue samples to discern the stages of AD progression without sectioning and staining the tissue. The Stokes polarimetry approach is highly sensitive to structural alterations of brain tissue, particularly to the changes in light scattering and birefringence. We present the results of the label-free non-destructive screening of FFPE mouse brain tissue and show several polarization metrics that demonstrate statistically significant differences for tissues at different stages of AD.",

keywords = "Ab plaques, Brain, Laser beams, Measurement by laser beam, Mice, Microscopy, Optical microscopy, Optical polarimetry, Polarimetry, Stokes vector, birefringence, scattering",

author = "Mariia Borovkova and Oleksii Sieryi and Ivan Lopushenko and Natalia Kartashkina and Jens Pahnke and Alexander Bykov and Igor Meglinski",

note = "This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/ Funding: This work was supported by the Academy of Finland (grants 314369 and 325097), the ATTRACT project funded by the EC under Grant Agreement 777222, the INFOTECH strategic fund. The work of Mariia Borovkova was also supported by the European Union{\textquoteright}s Horizon 2020 research and innovation programme under the Marie Sk{\l}odowska-Curie grant agreement No.713606. The work of Jens Pahnke was supported by the following grants: Deutsche Forschungsgemeinschaft/ Germany (DFG 263024513); Latvian Council of Science/ Latvia (ShortAbeta lzp-2018/1-0275); HelseS{\O}/ Norway (2019054, 2019055); EEA grant/Norges grants (TA{\v C}R TARIMAD TO100078); Norges forskningsr{\aa}det/ Norway (260786 PROPAD, 295910 NAPI, PETABC); European Commission (643417). PROP-AD and PETABC are EU Joint Programme - Neurodegenerative Disease Research (JPND) projects. PROP-AD is supported through the following funding organizations under the aegis of JPND - www.jpnd.eu. The research was also partially supported by a grant under the Decree of the Government of the Russian Federation No. 220 of 09 April 2010 (Agreement No. 075-15-2021-615 of 04 June 2021) and the Ministry of Science and Higher Education of the Russian Federation within the framework of state support for the creation and development of World-Class Research Centers “Digital biodesign and personalized healthcare” № 075-15-2020-926 ",

year = "2021",

month = nov,

day = "22",

doi = "10.1109/TMI.2021.3129700",

language = "English",

}

TY - JOUR

T1 - Screening of Alzheimer’s disease with multiwavelength Stokes polarimetry in a mouse model

AU - Borovkova, Mariia

AU - Sieryi, Oleksii

AU - Lopushenko, Ivan

AU - Kartashkina, Natalia

AU - Pahnke, Jens

AU - Bykov, Alexander

AU - Meglinski, Igor

N1 - This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/ Funding: This work was supported by the Academy of Finland (grants 314369 and 325097), the ATTRACT project funded by the EC under Grant Agreement 777222, the INFOTECH strategic fund. The work of Mariia Borovkova was also supported by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No.713606. The work of Jens Pahnke was supported by the following grants: Deutsche Forschungsgemeinschaft/ Germany (DFG 263024513); Latvian Council of Science/ Latvia (ShortAbeta lzp-2018/1-0275); HelseSØ/ Norway (2019054, 2019055); EEA grant/Norges grants (TAČR TARIMAD TO100078); Norges forskningsrådet/ Norway (260786 PROPAD, 295910 NAPI, PETABC); European Commission (643417). PROP-AD and PETABC are EU Joint Programme - Neurodegenerative Disease Research (JPND) projects. PROP-AD is supported through the following funding organizations under the aegis of JPND - www.jpnd.eu. The research was also partially supported by a grant under the Decree of the Government of the Russian Federation No. 220 of 09 April 2010 (Agreement No. 075-15-2021-615 of 04 June 2021) and the Ministry of Science and Higher Education of the Russian Federation within the framework of state support for the creation and development of World-Class Research Centers “Digital biodesign and personalized healthcare” № 075-15-2020-926

PY - 2021/11/22

Y1 - 2021/11/22

N2 - The minimum histological criterion for the diagnostics of Alzheimer’s disease (AD) in tissue is the presence of senile plaques and neurofibrillary tangles in specific brain locations. The routine procedure of morphological analysis implies time-consuming and laborious steps including sectioning and staining of formalin-fixed paraffin-embedded (FFPE) tissue. We developed a multispectral Stokes polarimetric imaging approach that allows characterization of FFPE brain tissue samples to discern the stages of AD progression without sectioning and staining the tissue. The Stokes polarimetry approach is highly sensitive to structural alterations of brain tissue, particularly to the changes in light scattering and birefringence. We present the results of the label-free non-destructive screening of FFPE mouse brain tissue and show several polarization metrics that demonstrate statistically significant differences for tissues at different stages of AD.

AB - The minimum histological criterion for the diagnostics of Alzheimer’s disease (AD) in tissue is the presence of senile plaques and neurofibrillary tangles in specific brain locations. The routine procedure of morphological analysis implies time-consuming and laborious steps including sectioning and staining of formalin-fixed paraffin-embedded (FFPE) tissue. We developed a multispectral Stokes polarimetric imaging approach that allows characterization of FFPE brain tissue samples to discern the stages of AD progression without sectioning and staining the tissue. The Stokes polarimetry approach is highly sensitive to structural alterations of brain tissue, particularly to the changes in light scattering and birefringence. We present the results of the label-free non-destructive screening of FFPE mouse brain tissue and show several polarization metrics that demonstrate statistically significant differences for tissues at different stages of AD.

KW - Ab plaques

KW - Brain

KW - Laser beams

KW - Measurement by laser beam

KW - Mice

KW - Microscopy

KW - Optical microscopy

KW - Optical polarimetry

KW - Polarimetry

KW - Stokes vector

KW - birefringence

KW - scattering

UR - https://ieeexplore.ieee.org/document/9622320/

UR - http://www.scopus.com/inward/record.url?scp=85120054352&partnerID=8YFLogxK

U2 - 10.1109/TMI.2021.3129700

DO - 10.1109/TMI.2021.3129700

M3 - Article

C2 - 34807820

SN - 0278-0062

JO - IEEE Transactions on Medical Imaging

JF - IEEE Transactions on Medical Imaging

ER -

Screening of Alzheimer’s disease with multiwavelength Stokes polarimetry in a mouse model

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this